Direct Biologics has developed the next generation of naturally bioactive products for regenerative therapies. Our novel technologies are used for developing Extracellular Vesicle (EV) products derived from adult human mesenchymal stem/stromal cells, which contain bioactive molecules with clinical therapeutic potential.